Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The case for stopping cervical screening at age 50

M E Cruickshank1, V Angus, M Kelly

  • 1Wellbeing Centre for the Prevention of Cervical Cancer, UK.

British Journal of Obstetrics and Gynaecology
|May 1, 1997
PubMed
Summary

Cervical cancer screening after age 50 is low-risk, primarily affecting inadequately screened women. Continuing regular cervical cytology screening for well-screened women over 50 shows minimal benefit, suggesting resource reallocation for high-risk individuals.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Alternatives to surveillance for persistent human papillomavirus after a positive cervical screen: A systematic review and meta-analysis.

European journal of obstetrics, gynecology, and reproductive biology·2024
Same author

European consensus statement on expert colposcopy.

European journal of obstetrics, gynecology, and reproductive biology·2023
Same author

European consensus statement on essential colposcopy.

European journal of obstetrics, gynecology, and reproductive biology·2020
Same author

Markers of the p53 pathway further refine molecular profiling in high-risk endometrial cancer: A TransPORTEC initiative.

Gynecologic oncology·2017
Same author

Is extending screening intervals safe in human papillomavirus-negative women?

BJOG : an international journal of obstetrics and gynaecology·2017
Same author

Reduction in colposcopy workload and associated clinical activity following human papillomavirus (HPV) catch-up vaccination programme in Scotland: an ecological study.

BJOG : an international journal of obstetrics and gynaecology·2017

Area of Science:

  • Gynecology
  • Oncology
  • Public Health

Background:

  • Cervical cancer screening guidelines vary by age, with a focus on younger populations.
  • Understanding cervical neoplasia patterns in older women is crucial for optimizing screening programs.

Purpose of the Study:

  • To investigate the incidence and patterns of abnormal cervical cytology in women aged 50-60.
  • To determine if cervical neoplasia in this age group is linked to inadequate prior screening.

Main Methods:

  • Retrospective case analysis of an 11-year birth cohort in Grampian Region.
  • Analysis of cytological and histological outcomes for women aged 50-60 with significant abnormalities.
  • Examination of screening intervals up to age 50 for affected women.

Related Experiment Videos

Main Results:

  • 1% of 23,440 women aged 50-60 had significant abnormalities; 70 had CIN 3, 15 invasive disease.
  • Inadequately screened women showed a higher prevalence of invasive disease (59/100,000) compared to well-screened women (11/100,000).
  • Only one case of CIN 3 and one invasive case were detected among ~9000 adequately screened women over 50.

Conclusions:

  • Preinvasive cervical disease is uncommon after age 50 and predominantly affects inadequately screened women.
  • Continuing routine cervical screening for women over 50 with adequate prior screening offers little benefit.
  • Reallocating resources to high-risk women and adjusting screening intervals could improve outcomes.